1. Atherosclerosis and Inflammatory Bowel Disease—Shared Pathogenesis and Implications for Treatment. (April 2021) Authors: Kamperidis, Nikolaos; Kamperidis, Vasileios; Zegkos, Thomas; Kostourou, Ioanna; Nikolaidou, Olga; Arebi, Naila; Karvounis, Haralambos Journal: Angiology Issue: Volume 72:Number 4(2021) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical, biomarker and endoscopic outcomes in patients with Crohn's disease treated with Ustekinumab: Multi‐centre real world study. Issue 3 (3rd May 2021) Authors: Kamperidis, Nikolaos; Fenech, Valerie; Thoua, Nora; Cole, Alexander; Segal, Jonathan P.; Peake, Simon; Arebi, Naila Journal: GastroHep Issue: Volume 3:Issue 3(2021) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study. Issue 11 (12th October 2018) Authors: Kopylov, Uri; Verstockt, Bram; Biedermann, Luc; Sebastian, Shaji; Pugliese, Daniela; Sonnenberg, Elena; Steinhagen, Peter; Arebi, Naila; Ron, Yulia; Kucharzik, Torsten; Roblin, Xavier; Ungar, Bella; Shitrit, Ariella Bar-Gil; Ardizzone, Sandro; Molander, Pauliina; Coletta, Marina; Peyrin-Biroulet,... Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study. Issue 11 (18th May 2018) Authors: Kopylov, Uri; Verstockt, Bram; Biedermann, Luc; Sebastian, Shaji; Pugliese, Daniela; Sonnenberg, Elena; Steinhagen, Peter; Arebi, Naila; Ron, Yulia; Kucharzik, Torsten; Roblin, Xavier; Ungar, Bella; Shitrit, Ariella Bar-Gil; Ardizzone, Sandro; Molander, Pauliina; Coletta, Marina; Peyrin-Biroulet,... Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 11(2018) Page Start: 2442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of therapeutic drug level monitoring on outcomes of patients with Crohn's disease treated with Infliximab: real world data from a retrospective single centre cohort study. Issue 4 (1st February 2019) Authors: Kamperidis, Nikolaos; Middleton, Paul; Tyrrell, Tracey; Stasinos, Ioannis; Arebi, Naila Journal: Frontline gastroenterology Issue: Volume 10:Issue 4(2019) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Issue 10 (26th April 2021) Authors: Kennedy, Nicholas A; Lin, Simeng; Goodhand, James R; Chanchlani, Neil; Hamilton, Benjamin; Bewshea, Claire; Nice, Rachel; Chee, Desmond; Cummings, JR Fraser; Fraser, Aileen; Irving, Peter M; Kamperidis, Nikolaos; Kok, Klaartje B; Lamb, Christopher Andrew; Macdonald, Jonathan; Mehta, Shameer; Poll... Journal: Gut Issue: Volume 70:Issue 10(2021) Page Start: 1884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Neurological disorders and small bowel dysmotility. Issue 3 (May 2022) Authors: Kamperidis, Nikolaos; Nightingale, Jeremy Journal: Current opinion in gastroenterology Issue: Volume 38:Issue 3(2022) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PTU-106 Improving care in inflammatory bowel disease outpatient clinics: first steps in delivering quality improvement. (8th June 2018) Authors: Kamperidis, Nikolaos; Barber, Susan; Akbar, Ayesha; Fofaria, Rishi; Alaa, Mohamed; Bailey-Fee, Susan; Bluston, Howard; Arebi, Naila Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Response to the Letter Regarding: Atherosclerosis and Other Cardiac Manifestations in Inflammatory Bowel Disease. (July 2021) Authors: Kamperidis, Vasileios; Kamperidis, Nikolaos Journal: Angiology Issue: Volume 72:Number 6(2021) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗